SLFN11 Is Necessary for Single Agent Sensitivity to Talazoparib, a Potent PARP Inhibitor, But Not for Radiosensitization in Small Cell Lung Cancer (SCLC) Cell Lines and Patient-Derived Xenografts (PDX)

Saved in:
Bibliographic Details
Published inInternational journal of radiation oncology, biology, physics Vol. 96; no. 2; p. S75
Main Authors Lok, B.H, Feng, Y, Gardner, E.E, Yu, G.K, Ru, Y.K, Riaz, N, deStanchina, E, Powell, S.N, Shen, Y.J, Poirier, J.T, Rudin, C.M
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.10.2016
Subjects
Hematology, Oncology and Palliative Medicine
Radiology
Online AccessGet full text

Cover

More Information
ISSN:0360-3016
1879-355X
DOI:10.1016/j.ijrobp.2016.06.191